Geralla, Chummy N.

HRN: 27-21-67  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/10/2025
CEFUROXIME 750MG (VIAL)
07/10/2025
07/17/2025
IV
500
Q8H
G1P0 Thickly MSAF
Checking Initial Appropriateness 
07/10/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/10/2025
07/16/2025
IV
500mg
Q8
G1P0 Thickly MSAF
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: